Last updated: October 19, 2022
Sponsor: National Cheng-Kung University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Genitourinary Prolapse
Uterine Disorders
Treatment
N/AClinical Study ID
NCT05586984
111-NCKUH-CTC--IIT
Ages > 21 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- older than 21 years old.
- uterine prolapse stage 2 at least, defined by C point distal to -1cm by POP-Q system.
- patients willing to receive a uterine-preserving surgery for pelvic organ prolapse,and is suitable for anesthesia after evaluation.
- patients who had or had not received conservative treatments for pelvic organprolapse.
- patients able and willing to finish the questionnaire evaluation.
Exclusion
Exclusion Criteria:
- patient who had received a previous hysterectomy, or is planning on concomitanthysterectomy in the surgery for pelvic organ prolapse.
- patient who had received a previous surgery for pelvic organ prolapse.
- patient with history of adverse events following a synthetic mesh.
- patients with chronic or acute pelvic pain.
- patients who had received abdominal or pelvic irradiation.
- patients who cannot receive either surgery due to comorbidity.
- patients pregnant or with future plan of pregnancy.
- patients with vaginal length less than 5cm.
Study Design
Total Participants: 90
Study Start date:
July 26, 2022
Estimated Completion Date:
December 31, 2029
Study Description
Connect with a study center
National Cheng Kung University Hospital
Tainan,
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.